ClinicalTrials.gg
WithdrawnNCT03049787Updated Jun 27, 2023

Formal Physical Therapy (PT) vs. Home PT for Adhesive Capsulitis

An interventional study of Home Exercise Protocol and Physical Therapy Protocol in Adhesive Capsulitis, sponsored by Boston Medical Center. Withdrawn. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-06-27.

Sponsored by Boston Medical Center · Not applicable, Interventional, and Treatment

Why this study was withdrawn
The study was never started as the PI was working on another clinical trial.
Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study aims to evaluate physical therapy (standard of care) and home exercise vs. home exercise alone for the treatment of adhesive capsulitis.

Read the detailed description

Patients with adhesive capsulitis receive a glenohumeral and subacromial injection routinely for treatment. In addition, the patients are routinely prescribed physical therapy with a home exercise component. The purpose of this study is to evaluate whether home exercise alone is an alternative option to physical therapy. Patients will be approached about the study after they have agreed to receive a glenohumeral and subacromial injection per standard of care for their clinical treatment. The hypothesis being tested is whether home exercise is alone is as beneficial for pain relief, restoration of range of motion, and improvement in shoulder disability from adhesive capsulitis as physical therapy. Additionally sex differences, diabetes mellitus, endocrine, and mental health histories will be noted.

02

Conditions studied

  • Adhesive Capsulitis

Browse trials for

Keywords

  • physical therapy
  • home exercise
  • adhesive capsulitis
03

In context

Bursitis

417 studies on the registry are indexed under Bursitis; 112 are open to participants now.

Browse Bursitis studies →

Lead sponsor

Boston Medical Center is the lead sponsor of 323 studies on the registry; 33 are open to participants now.

Of its 34 completed or terminated interventional studies of FDA-regulated products, 28 (82%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Clinical Diagnosis of Adhesive Capsulitis (limited range of motion)
  2. Given glenohumeral and subacromial injection as part of standard care.
  3. Capacity to conduct home exercise program or physical therapy (based upon physician judgment, proximity to physical therapy office and as decided by patient)
  4. English speaking
  5. 18 years of age or greater

Exclusion criteria

Exclusion Criteria:

  1. Prior glenohumeral or subacromial corticosteroid injection within 6 months
  2. Prior ipsilateral shoulder surgery
  3. Current prescription (narcotic) pain medication use
  4. Pain disorder (ex. Fibromyalgia, Reflex Sympathetic Dystrophy)
  5. Cervical radiculopathy
  6. Full-thickness rotator cuff tear
  7. Calcific Tendinopathy (past or present)
  8. Advanced Stage osteoarthritis as seen on radiograph
  9. Past/present ipsilateral shoulder fracture
  10. Women that may be pregnant or nursing (self report)

Past/present physical therapy treatment will be documented, but will not be considered an exclusion factor. The reasoning behind this is that the physical therapy likely was not properly targeting the adhesive capsulitis for the patient to arrive in an orthopaedic clinic and is likely at a similar starting point to most other patients regardless of previous physical therapy. All patients currently enrolled in physical therapy will be assigned to either our physical therapy or home exercise program.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
0 participants (actual)

Study arms

  • Experimental
    home exercise

    For the home exercise protocol alone arm, subjects will be given an experimental home exercise program and study team will demonstrate the exercises in the clinic and will direct the subjects to perform the exercises 1-2 times daily until symptom resolution.

    Other: Home Exercise Protocol

  • Active comparator
    physical therapy

    Patients will be prescribed routine physical therapy protocol where they will see a physical therapist twice a week and will be instructed by the physical therapist to perform physical therapy exercises at home daily until symptom resolution, as is the routine practice.

    Other: Physical Therapy Protocol

Interventions

  • OtherHome Exercise Protocol

    Home exercise therapy protocol given to patient to be completed at home.

  • OtherPhysical Therapy Protocol

    Formal physical therapy protocol to be given to physical therapist working with patient to direct formal intervention along with a home therapy protocol.

06

What researchers measure

Primary outcomes

  1. Change in Shoulder Pain and Disability Index(SPADI)

    shoulder pain and disability index to evaluate shoulder pain and function

    Time frame: 6 months compared to baseline score

Secondary outcomes

  1. Change in Range of Motion (ROM)

    evaluate range of motion

    Time frame: 6 months compared to baseline score

  2. Change in Sane Normal and Pain Visual Analogue Score (SANE)

    Subjective shoulder score to determine shoulder pain/function

    Time frame: 6 months compared to baseline score

  3. Change in Mental Health Index- 5 (MHI-5)

    Mental Health Index- 5 to determine patient mental health status

    Time frame: 6 months compared to baseline score

  4. Change in Short Form- 36 (SF-36)

    Short Form Survey- 36 to determine general overall health for patient

    Time frame: 6 months compared to baseline score

  5. Change in Visual Analog Scale Pain (VAS-Pain)

    Visual analog scale- pain to assess shoulder pain

    Time frame: 6 months compared to baseline score

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Jun 2022.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 7, 2017
First posted
Feb 10, 2017
StartEst.
Jun 2022
Primary completionActual
Jul 30, 2022
CompletionActual
Jul 30, 2022
Last update
Jun 27, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 27, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03049787
Responsible party
Sponsor
First posted
Feb 10, 2017
Start date
Jun 2022 (estimated)
Primary completion
Jul 30, 2022
Completion
Jul 30, 2022
Last update
Jun 27, 2023

Study contacts

Xinning Li, MD
principal investigator · Boston Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Jun 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion